List of Biotech, Pharmaceutical & Life Sciences companies in Georgia - 72

Accuitis Pharmaceuticals, Inc. is a US registered company with commercial operations located in Atlanta, GA. Accuitis is a participant in the Georgia Research Alliance Venture Lab program and our key technology was discovered by Emory University. We are engaged in the acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states. Our lead product is a transformational first in class treatment for Rosacea.

Altesa is a clinical-stage pharmaceutical company dedicated to developing new treatments for age-old threats to human health: high-consequence viral infections. These infections are particularly severe in vulnerable people, including those with chronic health conditions, like lung diseases, as well as the elderly and many people in underserved communities. Altesa builds upon a proven, highly successful drug development platform that has already prevented countless deaths from the two most impactful pandemics of the past 100 years—HIV/AIDS and COVID-19. Our objective is to develop safe and effective antiviral medicines in simple oral dosage forms that, when prescribed for the right people at the right time, will halt the progression of infection before it becomes serious—or even prevent the infection altogether. This strategy extends the proven benefits of testing for viruses such as the flu or COVID-19, which have both caused suffering and death among vulnerable people but can be treated if properly diagnosed. Viral pathogens like these and others have plagued mankind for many thousands of years, but testing for and treating them is an effective strategy to blunt their impact and, ideally, to defeat them.

Alzamend Neuro, Inc., a preclinical stage biopharmaceutical company, focuses on developing products for the treatment of neurodegenerative diseases and psychiatric disorders. The company’s lead product candidate is AL001 for the treatment of Alzheimer’s and other neurodegenerative diseases and psychiatric disorders. It is also developing AL002, a cell-based therapeutic vaccine, which seeks to restore the ability of the patient’s immunological system to Alzheimer’s. The company was incorporated in 2016 and is headquartered in Tampa, Florida.

AMD Biotech, Inc. was founded with a prime focus on the development of nano-magnetic bead technology and its capabilities. Through in-depth research and development, AMD Biotech, Inc. has established the unique technology and production system of nano-magnetic particles for array of products.

Andson Biotech is dedicated to advancing mass spectrometry workflows by enabling simple and fast sample-to-analysis workflows. Andson's DynaChip platform leverages advanced microfluidics packaged into an easy-to-use system to make sample prep for mass spec faster (and easier) for everyone. Our platforms are designed to be flexible - they couple with any commercial MS system for on-demand mass spec analysis with no expert training required. Our focus today is on improving sample preparation and workflow integration so that everyone can get more out of their mass spec.

Anitox works on protecting the food supply. By understanding how pathogens and other unwanted microbes occur, survive and thrive, the companydelivers commercially viable solutions in the areas of livestock and pet food production, feed milling and fermentation.

Artelon is the leader in dynamic augmentation of tendon and ligament reconstruction. Specifically designed bio-textiles resiliently reinforce the repair of soft tissue: uniquely restoring native motion, resisting the degradation of reconstruction strength, and supporting tendon and ligament regeneration. Dynamic innovations focused on getting people back to motion faster, stronger, and more stable. Learn more by visiting our website or by subscribing to the Artelon YouTube channel.

Artivion is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. Our purpose is to develop simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with diseases of the aorta and deliver breakthrough technologies of unsurpassed quality that have far-reaching impact. Our decades of expertise in treating aortic diseases—coupled with our recent acquisitions and partnerships—have empowered us to offer cardiac and vascular surgeons a suite of aortic-centric solutions such as cryopreserved cardiac and vascular allografts, surgical sealants, prosthetic heart valves, and aortic stents and stent-grafts. Artivion has over 1,250 employees worldwide with sales representation in over 100 countries. The Company has manufacturing facilities located in Atlanta, Georgia, Austin, Texas, and Hechingen, Germany. Additionally, it has sales and distribution offices in various countries throughout Europe, Asia, and South America.

Aruna Bio is harnessing the natural abilities of neural exosomes to cross the blood brain barrier and enhance the body’s anti-inflammatory, self-repair and protective mechanisms to treat a range of neurodegenerative disorders. We are leveraging our proprietary exosomes and manufacturing platform to create synergistic therapies by enhancing our exosomes with small molecules, RNA, oligonucleotides and antibodies.

Athens Research and Technology, Inc. (ART) is a dynamic life science company and recipient of the Globe Award as Georgia's 2022 Exporter of the Year. Since our founding over three decades ago, we continue to proudly support the life sciences industry in the advancement of essential medical diagnostics and therapies. ART is renowned for defining the industry standard for native protein purification. We specialize in producing natural human and animal proteins critical to academic research and manufacturing in the Clinical Diagnostic, Cell Culture Media, and Standards/Calibration industries. Our custom purification programs support our long-standing distinguished industry partners as well as our growing base of inspired customers. Since 1986, ART products have been sought after by prominent academic researchers and biotech companies for high-impact research published in Nature, Science, & Cell journals. ART proteins have been crucial for Alzheimer's, Cancer, Cardiac, Pulmonary, and Covid-19 research. Envisioned by local physicians and a university of Georgia researcher, ART was one of the first Life Science start-ups to launch from the University of Georgia incubator. Since our inception, we have served as a model for success to many subsequent companies. We are committed to People, Purpose, & Proteins. People are at the core of our belief system. Our culture continues to attract great talent, developing the next generation of industry-leading Protein Chemists. Purpose is ingrained in our being, keeping quality proteins at the forefront of research for the world's most complex medical challenges. Our purpose overflows into the Athens, GA, community as we ensure the health and strength of our neighbors and the growth of our local economy. Proteins are the core of our success. After 36 years, our company holds a breadth of knowledge of proteins and purification processes, allowing us to purify even the most complex and least abundant proteins in the human body.

Founded in 2015 by former healthcare entrepreneurs, Avego is a multi-strategy healthcare-focused investment firm with offices in New York and Georgia. Through its three strategies, which include private equity, venture capital, and a long/short fund, Avego invests in private and public companies developing and commercializing innovative products and services for patients, practitioners, and other stakeholders across the healthcare continuum. Avego Healthcare Capital provides growth capital to revenue-generating businesses and partners with entrepreneurs to build new companies. Avego BioScience Capital focuses on mid-to-late stage venture financings for life sciences companies. Velan Capital is actively investing in publicly traded companies in the healthcare sector with a focus on undervalued assets and high-quality management teams.

AventaCell BioMedical Co., Ltd. ("AventaCell") is among the world leaders devoted to developing novel human-derived products for use in cell culture and tissue regeneration. Helios Bioscience is AventaCell's product family brand for their products to be used in cell culture and tissue regeneration. AventaCell technologies used in the Helios Bioscience line offer new human-derived solutions for use in translational research of cell and tissue-based therapies to meet the need for animal serum-free cell expansion and production. The demand for safe, efficient and cost-effective cell expansion and production is rapidly increasing with the growth in cell therapy and regenerative medicine research and clinical development. Helios Bioscience products are designed to support expansion and production of a broad range of cells including mesenchymal stem cells and multiple immunocell lines. AventaCell is committed to providing animal serum-free products to accelerate the research, development and commercialization of safe and efficacious cell and tissue-based therapeutics.

Bako Diagnostics is a provider of diagnostic and therapeutic services with a unique focus on pathology of the lower extremity. Bako's comprehensive testing menu includes ENFD Analysis, Mass Spectrometry, for rapid identification of bacteria from culture specimens, and Molecular Genetics for the detection of micro-organisms and as a diagnostic aid in certain pathologic diagnoses. Bako's in-network services are available through its more than 200 million covered lives, including all five national health plans and fully compliant patient-friendly billing policies. Over the past nine years, Bako has evolved into one of the podiatric profession's principal sources of educational sponsorship. Bako Diagnostics, your professional partner for disease diagnostics and management! For more information, call us at 855-422-5628 or visit bakodx.com.

With a relentless mission to empower those seeking answers to life’s important scientific questions, Beckman Coulter Life Sciences is a preferred laboratory partner providing automation and innovation solutions for Centrifugation, Flow Cytometry, Genomics, Particle Analysis, and Liquid Handling workflows. With a legacy dating back to 1935, our technologies reduce manual laboratory processes and can provide greater speed, accuracy, and advanced analytics to accelerate answers with a guiding focus to improve patient care and enable pioneering discoveries. Beckman Coulter Life Sciences is headquartered in Indianapolis, Indiana with 11 operational hubs around the world and employs more than 3,300 associates with more than 300,000 systems installed globally.

Novoste is the global leader in the field of vascular brachytherapy.

BioCircuit is a medical device company that specializes in advanced solutions for tissue repair and neuromodulation, highlighted by their innovative product, Nerve Tape®, the first sutureless device for repairing transected nerves.

BioGeometry is an AI-driven biotech dedicated to developing next-generation, programmable protein medicines. We aim to solve the high cost, long lead time, low success rate problems for traditional macromolecular theraputics through the combination of geometric deep learning, structural biology, immunology, and synthetic biology. We enjoy talents from renowned pharmaceutical companies, top-tier AI and bio labs worldwide.

Imagine you need to send a message to a friend. You could mail a letter and they might receive it in a few days. You could drive to their home to tell them the news, dealing with traffic along the way. But, wouldn't it be simpler to just pick up your phone and call or text? It's better. It's faster. At Brain Trust Bio, we are giving life-altering medicines a direct route to the body without the roadblocks and side-effects commonly associated with other drug delivery methods. Now launching Phase I trials in Australia for our revolutionary Intrathecal Drug Delivery Method. The equivalence of these Phase I trials to American standards ensures that findings will be directly accepted in the U.S., allowing for an immediate advancement to Phase II without the need for repetition. Focusing on IT-Riluzole (the only drug demonstrated to prolong survival in ALS), the trials will involve 10 patients over a six-month period and will be conducted by leading medical professionals at Flinders University, Adelaide, and Sunshine Coast Hospital, Birtinya. Brain Trust Bio, an industry leader with a proven track record, which has already shown promising potential. Notably, two patients have been treated for over two years without observed side effects, offering promising indications of the method's ability to extend life expectancy. We are committed to patients because with CNS disorders—like ALS and multiple sclerosis—every second, minute, or hour is more time with loved ones and a step closer to a cure. With ALS—the typical survival rate is two to five years from the time of diagnosis. During that time, those affected lose abilities we often take for granted like walking, talking, and eating independently. They miss important life events like birthdays, anniversaries, or their child's graduation. Brain Trust Bio is making improvements to precision drug delivery and enhancing already available treatments to accelerate positive patient outcomes. Find out more at: www.braintrustbio

Cambium Oncology is a team of scientists, drug development experts, cancer physicians, and business leaders united in a shared vision of treating cancer with a novel immunotherapeutic that targets the VIP signaling pathway. Emory investigators discovered that small molecule antagonists to the VIP receptor on T cells could augment T cell-mediated immune responses to cancer, viral infections, and vaccines. Cambium scientists developed and patented more potent molecules with longer half-lives that induce potent anti-cancer immune responses to leukemia and pancreatic cancer. Cambium Oncology is poised to transform the immuno-oncology field, with a first-in-class therapeutic against a novel immune checkpoint pathway.

City of Johns Creek is a Georgia-based public administration that develops and manages human resources, economic development, and waste management for Johns Creek residents.

Clearside Biomedical, Inc., a biopharmaceutical company, engages in the developing and delivering treatments that restore and preserve vision for people with serious eye diseases. Its product includes CLS-AX, an axitinib for suprachoroidal injection which is in Phase 1/2a clinical trial. It also develops XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of macular edema associated with uveitis, diabetic macular edema, and macular edema associated with retinal vein occlusion. The company was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

CorDx a multi-national biotech organization focused on pushing the limits of innovation and supply in global health. With over 2,100 employees across the world, serving millions of users in over 100 countries, CorDx delivers rapid testing and point-of-care medical device solutions used in the detection of infectious disease such as COVID-19, pregnancy, drugs of abuse, biomarkers, and more. CorDx is at the cutting edge of technology, artificial intelligence, and data science with the goal of delivering diagnostic solutions to some of the most critical questions in healthcare. #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

Danimer Scientific, producer of biopolymers in Bainbridge, GA – manufactures PHA bioplastics from renewable, natural resources. Danimer plastics are 100% biodegradable and compostable, and equal or exceed petroleum-based plastic commodities for price and performance. Danimer Scientific creates bioplastic feedstock from canola oil, enabling global brand owners to utilize environmentally responsible materials in products that consumers purchase every day. Danimer makes commercial grade PHA using world-class production systems, offering a scalable, durable, and cost effective material that reduces manufacturing dependence on non-renewable, diminishing resources. Danimer also offers specialty toll manufacturing at their facility. Danimer provides their state of the art production equipment, laboratories, material handling and logistics, as well as their fully trained and experienced staff to other companies.. Danimer uses the customer's formulations, materials and instruction to produce quality products to the client's specifications.

Dogwood is pioneering Halneuron®, a highly selective sodium channel blocker being developed to treat moderate-to-severe chemotherapy induced neuropathic pain (CINP), cancer pain, and other pain indications. It is also developing the antiviral combination therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID (“LC”) and fibromyalgia (“FM”)

Dr. Reddy's Laboratories is a pharmaceutical company that specializes in pharmaceutical manufacturing and healthcare products.

Emory Healthcare is the most comprehensive health care system in Georgia. We offer 11 hospitals, the Emory Clinic, more than 250 provider locations, and more than 2,800 physicians specializing in 70 different medical subspecialties. Meaning we can provide treatments and services that may not be available at local community hospitals. That's the Emory Difference.

Emory University is an academic institution that offers a wide range of undergraduate, graduate, and research programs.

Exide Technologies, LLC, as a part of Exide Holdings, Inc., filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware on May 19, 2020. Through a court-supervised auction both the Americas battery manufacturing and recycling businesses and the Europe, Middle East and Africa (EMEA)/Asia-Pacific (APAC) battery manufacturing and recycling businesses were sold to separate buyers in August 2020 and October 2020 respectively. For more information, visit https://cases.primeclerk.com/Exide2020/.

Expression Therapeutics, Inc. is a fully integrated clinical stage gene and cell therapy company developing novel, potentially curative, therapeutics for hematology and oncology. The Company, based in Atlanta, Georgia, has a state-of-the-art 43,000 square foot manufacturing facility in West Chester, Ohio. Expression Therapeutics, Inc. also built a state-of-the-art scalable 43,000 square foot manufacturing facility in Cincinnati, Ohio.

Femasys is a biomedical company focused on transforming women's healthcare worldwide by developing novel solutions and next-generation advancements providing significant clinical impact to address severely underserved areas. With an initial focus in the area of reproductive health, its two lead product candidates offer solutions to improve patient care and health economics: FemBloc®, a first and only non-surgical product for permanent birth control and FemaSeed™, a first and only directed sperm delivery product for infertility treatment. Femasys' FemVue® product for fallopian tube assessment by ultrasound is currently marketed in the United States as its main commercial priority. Femasys has also developed a novel technology platform for tissue sampling intended to be marketed alongside our other women-specific medical products in the physician's office setting.

FERMWORX is a biotechnology company that specializes in producing high-performance biopolymer-based and bio-based fermentation products, offering product development and toll manufacturing services with a focus on renewable and sustainable practices.

CAFST has an enrollment of approximately 500 (growing) undergraduate and graduate students. We are extremely proud of the College's students and its wide recognition for excellence in undergraduate education, research and outreach programs. The College is ranked 25th nationally in the production of African American Agriculturists. CAFST has also been the University's leader in placing first time applicants into medical, dental, veterinary and pharmacy Schools/Colleges since 2001. The College has some of the most modern and well-equipped laboratories in the state and our scientists are securing external grant funds and conducting cutting edge research. Our students work with the scientists in these laboratories and is part of the reason for our national ranking and our students' ability to enter professional and graduate schools.

Galectin Therapeutics (NASDAQ: GALT) is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on the Company’s unique carbohydrate technology target galectin proteins which are key mediators of biologic and pathologic function. We use naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates with specific molecular weights. Using these unique carbohydrate-based candidate compounds that bind and inhibit galectin proteins, we are pursuing therapies for indications where galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life threatening consequences to patients, and those where current treatment options are limited. Our strategy is to establish clinical development approaches that add value to the Company in the shortest time possible, and to seek partners as the program advances and requires much greater resources. We are pursuing a clear development pathway to clinical enhancement and commercialization for our lead compounds in liver fibrosis, tumor vaccine enhancement, and colorectal cancer. We also have a colorectal cancer program moving towards commercialization in foreign locations based on medical needs in those regions.

GeneCure Biotechnologies is a biotechnology company that focuses on developing gene therapy based technologies to treat genetic and acquired human diseases.

We are Genesis Biosciences - a global biosciences company, based in both Atlanta, US, and Cardiff, UK. We have the unique capability to ferment bacteria strains and develop safe and natural microbial and antimicrobial products on a solid foundation of eco-benign technology. Using a combination of these technologies, we create environmentally-responsible products and solutions with a wide range of applications to meet our customers’ needs. Our manufacturing and laboratory facilities, strategically based in both the United States and Europe, enable us to provide unrivaled global technical support for our customers.

The Georgia Genomics and Bioinformatics Core (GGBC) is the University of Georgia (UGA) core laboratory for nucleic acid sequencing and bioinformatics. Theirmission includes research support, education, and training. Theirservices are available to university and industry researchers.Theirservices encompass the range of genomic techniques and applications, sequencing technologies, and bioinformatics analyses. GGBC operates multiple platforms for short-, long-, and single-molecule sequencing reads (i.e., Illumina MiSeq and NextSeq, PacBio Sequel, and Oxford Nanopore MinIon). Theyalso write letters of support (LOS) to offer theircapabilities and expertise for grant applications submitted to funding agencies.

The Georgia Institute of Technology is one of the nation's premier research universities providing a focused, technologically based education to more than 25,000 undergraduate and graduate students . Ranked seventh among U.S. News & World Report's top public universities, Georgia Tech offers degrees through the Colleges of Business, Computing, Design, Engineering, Liberal Arts and Sciences. The Institute offers research opportunities to both undergraduate and graduate students and is home to more than 100 centers that consistently contribute vital innovation to American government, industry, and business.

GeoVax Labs, Inc., (NASDAQ: GOVX) is a clinical-stage biotechnology company developing human vaccines against infectious diseases using our Modified Vaccinia Ankara - Virus-Like Particle (MVA-VLP) vaccine platform. Our current development programs are focused on vaccines against COVID-19; Hemorrhagic Fever viruses such as Ebola (Zaire, Sudan), Lassa and Marburg; Malaria and Zika virus; and, Human Immunodeficiency Virus (HIV). We have also initiated programs to develop a broadly applicable immunotherapy against tumor associated antigen MUC1 that is expressed of many solid tumor types including breast, ovarian, gastric, liver, pancreas, renal and lymph nodes and immunotherapy to treat human papilloma virus (HPV)-induced cancers.

In 2015, two cousins from Georgia Tech founded Grubbly Farms, a startup in Atlanta pioneering the use of sustainable insect-based protein in pet food. Grubbly's protein of choice? Black soldier fly grubs. Loaded with benefits and light on the earth. Our grubs are harvested on food that would otherwise go to waste, providing relief to our landfills and combatting our world's massive food waste issue. 

These nutrient-rich grubs have the power to replace conventional protein such as fishmeal, providing a healthy, hypoallergenic protein to our pets while providing relief to our overfished oceans. Unlike other companies using environmentally-friendly insect protein, Grubbly has a unique go-to-market strategy that's transforming how we feed our pets while disrupting the ag industry, and accelerating the production of grubs on sustainable farms around the world. What kind of pets are gobbling up all of these grubs? Chickens from coast to coast are naturally loving Grubbly's pet food. Over 6% of Americans own chickens as pets, and they prioritize high quality feed and snacks. When you're eating your flock's eggs, you have higher standards for what your flock eats. With premium nutrition, highly traceable ingredients, and sustainably-grown grubs, Grubbly Farms is helping backyard chickens return to their roots using insect protein and plant-based foods. Backyard chicken owners will also be the leaders and pioneers of a more sustainable protein for all pets. In fact, dogs and cats are drawn to the naturally sweet smell of grubs, generating demand for Grubbly pet food for companion pets too. As the Grubbly brand continues to blossom, we can keep our pets happily nourished while helping our planet thrive.

Guided is a Georgia-based medical technology company that develops and commercializes non-invasive medical devices for early detection of cancer.

Immucor is a Georgia-based healthcare technology company that develops transfusion and transplantation diagnostic equipment for hospitals and clinical laboratories.

Inhibikase Therapeutics (Nasdaq: IKT) is a clinical-stage pharmaceutical company focused on developing and commercializing small-molecule kinase inhibitor therapeutics that modify Parkinson's disease and drive functional reversal inside and outside of the brain. Inhibikase is headquartered in Atlanta, Georgia with additional offices in Boston, Massachusetts.

The Institute of Bioinformatics's mission is to facilitate cutting-edge interdisciplinary research in bioinformatics/computational biology and its application. We train graduate students to tackle complex biological problems which utilize omics or other complex data types.

Ipsum Diagnostics is a nationally acclaimed molecular diagnostics laboratory, renowned for its expertise in identifying infectious disease pathogens and antibiotic resistance genes. Our molecular panels leverage the power of polymerase chain reaction (PCR) technology and provide fast results for more effective treatment that leads to improved patient outcomes. Located in Atlanta, GA, our state-of-the-art laboratory specializes in molecular and anatomical pathology. We accommodate workflow needs by providing services such as customized reports, statistical analysis of patients with different treatment plans, and meaningful data to assess overall treatment performance amongst patient populations. Our comprehensive and succinct patient reports can be made available via EMR integration, portal access, fax, or our easy to use mobile or tablet app. Ipsum's software capabilities allow for a superior customized experience, with the highest quality standards that will have your reports completed promptly and efficiently. Ipsum Diagnostics creates a true partnership environment between Provider, Patient, and Laboratory. For locations needing a UPS pickup please follow the below instructions: 1. Call (800) PICKUPS 2. When prompted reply "Schedule a pick"​ 3. You will be asked for your phone number 4. Be prepared to have tracking number ready to provide 5. Provide address of pick up with a time frame UPS Phone Center Shortcuts: https://www.ups.com/us/en/contact/ivr-Popup.page?

For over 57 years J&J has built a worldwide reputation for innovations in the portable sanitation industry with effective Odor Control Solutions and exceptional customer service. J&J now offers the Echo line of strong, smart, & durable portable toilets and sinks loaded with features and built for the long haul. Cutting no corners on design or research, our devotion to excellence in service, quality, and understanding the portable sanitation industry gives our customers the advantage they need for success.

Koning Corporation develops and manufactures advanced medical imaging systems for breast cancer detection using cone-beam computed tomography technology. This revolutionary technology provides true 3D images for early breast cancer detection, providing a significantly more accurate and effective test than mammography and tomosynthesis. Koning's vision is to fundamentally change breast cancer is detected and diagnosed, with earlier detection, increased patient comfort and lower costs. We believe our Koning Breast CT will dramatically improve the way clinicians visualize and evaluate breast tissue. We believe that the power, versatility and lower cost of Koning Breast CT will serve as a viable substitute for many traditional imaging applications. Our hope is to be able to improve survival rates and outcomes for millions of patients. Koning Corporation's core technologies are protected by over 80 patents globally, and has received regulatory approval in the US (FDA), Europe (CE-Mark), China (CFDA), Australia (TPG), and Canada (Health Canada). Koning has been the beneficiary of over $17 M in venture funding and over $20 M in government grants to bring this exciting technology to market. Future versions of our technology are expected to optimize early disease detection, diagnosis, intervention and treatment in numerous areas of the body.

At Kura Biotech, our dedication is grounded in the strong belief and conviction that we can generate a positive impact in the World by helping laboratories with their most complex challenges and by providing scientists with the fastest and the highest performing enzymes for sample preparation. After developing revolutionary solutions in toxicology through our Finden brand, we are now expanding our expertise to the genetics and proteomics industry with two new brands: Avenire and Blikka. We thrive to face challenges through our four core commitments: human connections, unlimited spirit, unapologetic standards, and give back will. Each year we contribute 2% of our revenues to the development of the community where we are located through three core fields: childhood, education, and environment. Where there is a will, there’s a way!

Lanier Biotherapeutics was founded by combining the businesses of Biophtha and Abeome, to further develop an existing first-in-class biologics portfolio for specialty disease, with the ultimate goal of improving the way we survive, age, and live. Lanier targets four major verticals: Multi-functional Retina, Type 2 Inflammation, Dermatology, and ImmunoOncology. Lanier’s lead developments programs include LNR 653.1, a fully humanized anti-VEGF / IL-17A multifunctional antibody for the treatment of retinal neovascularization diseases and LNR 125.36, a fully humanized anti-IL-25 monoclonal antibody for the treatment of Type 2 Inflammatory diseases.

Lectenz Bio is developing novel products that employ our unique Lectenz® reagents and GlycoSense™ technology, to speed up and simplify the detection and discovery of disease biomarkers. These products enable targeting glycan biomarkers of clinical significance for investigation and leveraging them for advancing human health. Glycan-based biomarkers are particularly important for disease diagnosis and clinical treatment, yet their discovery and detection is challenging, due to the lack of glycan-specific reagents and tools. We are meeting this important need by developing innovative technologies in the glycosciences that will advance critical research and clinical applications. We are excited about helping to improve human health in this underexploited area. The company’s mission is to develop technologies that enable novel glycoscience applications, provide services that enhance glycan biomarker detection, and deliver tools that advance research and clinical applications.

Metaclipse Therapeutics is a preclinical stage biotech company developing novel cancer therapies that are tailored to each patient and their specific tumor. The Company’s first ‘personalized’ cancer therapy is for triple negative metastatic breast cancer. Metaclipse intends to commercialize its products through licensing agreements with major pharmaceutical companies after establishing their safety and effectiveness in early clinical trials by year-end 2019.

Micron Biomedical, Inc. is a clinical-stage biopharmaceutical company on a rapid path to bring to market drugs and vaccines that are formulated into a proprietary patch technology that simplifies and improves the way actives are delivered, stored, and distributed. This technology is designed to increase patient access to drugs and vaccines that would otherwise require expert injection and to improve safety and efficacy by skin targeting.

MIMEDX Group is a biotechnology company that specializes in regenerative medicine and tissue engineering products.

Moonlight Therapeutics is focused on developing safe, effective, and patient-friendly treatments for people suffering from food allergies. Our first treatment is for children and adults with peanut allergies.

Founded in 1990, MVA Scientific Consultants is a leading full-service analytical microscopy laboratory offering customized testing solutions across industries such as environmental forensics, industrial hygiene, pharmaceuticals, and nanomaterials. Our expertise in microscopy supports regulatory compliance, quality assurance, litigation, and R&D projects. We are ISO/IEC 17025 accredited, cGMP compliant, DEA licensed, and FDA registered, ensuring high-quality reporting and strict client confidentiality. Visit our website to learn more about how MVA Scientific Consultants can assist you with your next project.

NeuroPn Therapeutics is a biopharmaceutical company focused on the discovery and development of novel therapies for neurodegenerative diseases with focus on chronic neuropathic pain and Parkinson’s disease. Developing Non-narcotic, Safe and Innovative Treatments for Neuropathic Pain NeuroPn is addressing the urgent opioid crisis and developing novel, safe, effective, and potentially disease modifying treatments for patients suffering from chronic pain. Developing Novel, Disease Modification Therapies for Parkinson’s Disease NeuroPn is aiming to transform treatments for neurodegenerative diseases and is developing innovative therapies with superior efficacy and improved safety profile over marketed drugs. NeuroPn approach has potential to halt or reverse Parkinson’s disease progression.

NeuroTrauma Sciences (NTS) is a biopharmaceutical company focused on developing therapies to treat the devastating effects of stroke and traumatic brain injury (TBI), including concussion. NTS is taking an innovative approach to the treatment of these conditions by addressing the fundamental underlying biological processes that enable the pathophysiological injury cascade.

NFANT Labs is an emerging digital health company focused on improving the outcomes and lives of Neonatal infants. The nfant® Feeding Solution is the first FDA cleared IoT medical device focused on the NICU. We are determined to guide infants to faster and safer feeding.

Noramco, headquartered in Wilmington, Delaware, is a global leader in the production of controlled substances for the pharmaceutical industry, for medicines used to treat attention deficit hyperactivity disorder, pain, addiction, and for abuse-deterrent formulations. We realize our success through a keen focus on commercial and operational excellence as well as continuing strategic growth. Our global footprint includes Athens, GA, Wilmington, DE and Neuhausen, Switzerland. Specialists in controlled substance development and manufacturing, Noramco is a partner to the pharmaceutical industry: – Focusing on high-purity controlled substances – Leveraging intellectual property to devise the most efficient routes to APIs – Providing analytical data, chemical and physical properties, stability studies and regulatory assistance – Formulation friendly particle size grades and extended technical packages – Delivering DEA-compliant security and production capacity, from kilos to multi-ton supply – Supporting world-class supply security of controlled-substances, from schedule I to schedule III

Oncorx Pharmaceuticals is an early-stage pharmaceutical company developing high-affinity drugs that selectively target the P-glycoprotein/CD44/Integrin β1 protein complex that is overexpressed on the surface of therapy-resistant tumors. Activation of α5β1 integrin plays an important role in regulating cytoskeletal reorganization, F-actin polarization, the epithelial-to-mesenchymal transition, anchorage-independent tumor cell growth, and tumor cell apoptosis. Currently available cancer therapies are targeted to primary, untransformed tumor cells and are not effective in treating resistant transformed tumors that have entirely different cell surface receptor targets and actin cytoskeletal organization. Oncorx is developing oncology drugs that not only target resistant tumors, but also effectively penetrate the blood-brain-barrier to reach the tumor sanctuary in the brain. Numerous clinical studies have demonstrated that patient survival is strongly dependent upon the time it takes for tumors to reach the brain from their primary site in the body.

Pharma Tech Industries (PTI) is a pharmaceutical contract manufacturing organization offering fully-integrated supply chain support and customized production services to many of the most trusted pharmaceutical and wellness companies in the world.

Piezo Therapeutics aims to transform the delivery of nucleic acid medicines to enable improved safety, affordability, and scalability. Piezo is developing a uniquely engineered platform that uses electric pulses and microneedles to deliver a broad range of therapeutics inside the body. Its piezoelectric technology offers improved safety and efficacy, and is simple, cost-effective, and rapid to produce at scale. Founded by experts in the field of drug delivery and commercial translation, Piezo's diverse team aims to help translate the next generation of nucleic acid medicines. For more information, please visit www.piezotx.com or email partnerships@piezotx.com.

We are experts in plasma energy with pioneering research in medical plasma technology and a robust patent portfolio. Our company was formed by technology leaders inspired by the potential to transfer the principles of plasma physics and apply these in medicine. From this, a new standard in surgery was born – plasma surgery – and with it, PlasmaJet - the first true plasma surgery system. This important advancement is helping surgeons perform better surgery and maximize clinical benefits for their patients. PlasmaJet has been used to treat more than 45,000 patients in more than 20 countries all over the world. Our Products have proven results and unique value supported by a large clinical database. For more information, please visit www.theplasmajet.com Indications for Use: PlasmaJet System produces plasma energy for dissection, cutting, coagulation and the removal of soft tissue by vaporization in open and videoscopic procedures.

RayBiotech is a leading life sciences company providing proteomic discovery tools to scientists in 85 countries worldwide. RayBiotech is committed to accelerating research through innovation, leadership, and excellent products and service.

Saol Therapeutics (pronounced "Sail") is a privately held, clinical-stage, pharmaceutical company with operations in Roswell, GA, Dublin, Ireland and Hamilton, Bermuda. The company is focused on development activity in CNS disorders such as pain management and spasticity and orphan diseases. Saol is committed to providing and advancing therapeutic options for patients and the physicians treating these populations and currently has two Phase 2 trials and one Phase 3 trail underway in the United States.

Sebela Pharmaceuticals is a U.S. pharmaceutical company with a market-leading position in Gastroenterology and a focus on innovation in Women’s Health. Our Vision is to build the leading Gastroenterology company in the U.S., with a complementary focus on innovation in Women’s Health, premised on our expertise in pharmaceutical development and commercialization. We value dedication, energy, and enthusiasm, and we focus on innovation and results while striving to achieve our corporate mission and vision. Sebela Pharmaceuticals is committed to cultivating an inclusive environment where all employees are treated with respect. We accomplish this by fostering a culture of diversity, equity and inclusion, which is essential to innovation and continuous improvement. Sebela operates from three locations with offices in Roswell, Georgia, Braintree, MA and headquarters in Dublin, Ireland.

Slingshot Biosciences is working on an overlooked but ubiquitous problem in healthcare that has a tremendous impact on a variety of patient outcomes: the lack of consistent reference material for cell-based assays. The company’s cell mimics represent a new way to use control material in the workflow, whether for instrument manufacturing, assay setup, and validation or as a manufacturing QC control. Synthetic cell mimics provide a new opportunity for precise, biologically-relevant, and cost-effective controls to aid many healthcare and research efforts globally. Learn more at slingshotbio.com

Cancer patients get one chance to save their tumor tissue. Don't throw it away. Unfortunately most tissue is routinely discarded, but SpeciCare aims to change that. Your tumor tissue is as unique as a fingerprint, and holds the key to more effective, precision treatments, leading to improved outcomes, and a better quality of life. We work with cancer patients, and their care team, to uncover treatment options not available without SpeciCare's innovative protocol. Call today to speak to one of our patient advocates. We care about you.

TopoDx is a biotechnology company that offers a microbial test to identify antibiotic resistance and susceptibility accurately.

Vernagen aims to discover and develop mRNA based therapeutics using highly advanced mRNA technologies. Our current pipeline includes vaccine platforms targeting various emerging pathogens and biologics platforms aiming to replace current protein based therapeutics. Our mRNA platforms employ multiple innovative chemical and biological components to enhance their therapeutic efficacy and safety.

Vero biotech is an emerging biotechnology company focused on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical needs of patients with cardiopulmonary conditions. At Vero Biotech, our mission is to improve the lives of patients by leading the development of innovative technologies for inhaled NO delivery in the acute care hospital setting and beyond, wherever Nitric Oxide treatment is needed. We strive to exceed customer expectations in terms of safety, efficacy, and growth by focusing on the science, development, and commercialization of our innovations.